Cargando…

Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis

BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Charan, Jaykaran, Tank, Nitish, Reljic, Tea, Singh, Surjit, Bhardwaj, Pankaj, Kaur, Rimplejeet, Goyal, Jagdish P., Kumar, Ambuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857375/
https://www.ncbi.nlm.nih.gov/pubmed/31742141
http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19
_version_ 1783470759535968256
author Charan, Jaykaran
Tank, Nitish
Reljic, Tea
Singh, Surjit
Bhardwaj, Pankaj
Kaur, Rimplejeet
Goyal, Jagdish P.
Kumar, Ambuj
author_facet Charan, Jaykaran
Tank, Nitish
Reljic, Tea
Singh, Surjit
Bhardwaj, Pankaj
Kaur, Rimplejeet
Goyal, Jagdish P.
Kumar, Ambuj
author_sort Charan, Jaykaran
collection PubMed
description BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult patients in India. METHODS: PubMed and Google Scholar were searched to find different observational studies reporting MDR-TB prevalence in India. Data related to MDR-TB prevalence were pooled for the analysis. PubMed was searched by using different MeSH words. Prevalence was reported with 95% confidence interval (CI). A separate analysis was done for new cases and previously treated cases. Random effect model was used and heterogeneity was assessed by I(2) and Cochran Q test. RESULTS: MDR-TB prevalence in new cases were 3% (95% CI 2%-5%, I(2) = 95.3%). There was difference in prevalence between different methods of measurement of MDR-TB and study designs. MDR-TB prevalence in previously treated cases was found to be 35% (95% CI 29%-41%, I(2) = 98.7%). Results vary with the method of measurement as well as the study design. CONCLUSION: MDR-TB prevalence in previously treated patients was found higher compared to the reported values in national surveys. There is a need for large scale cross-sectional study to verify the findings observed in this review.
format Online
Article
Text
id pubmed-6857375
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68573752019-11-18 Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis Charan, Jaykaran Tank, Nitish Reljic, Tea Singh, Surjit Bhardwaj, Pankaj Kaur, Rimplejeet Goyal, Jagdish P. Kumar, Ambuj J Family Med Prim Care Original Article BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult patients in India. METHODS: PubMed and Google Scholar were searched to find different observational studies reporting MDR-TB prevalence in India. Data related to MDR-TB prevalence were pooled for the analysis. PubMed was searched by using different MeSH words. Prevalence was reported with 95% confidence interval (CI). A separate analysis was done for new cases and previously treated cases. Random effect model was used and heterogeneity was assessed by I(2) and Cochran Q test. RESULTS: MDR-TB prevalence in new cases were 3% (95% CI 2%-5%, I(2) = 95.3%). There was difference in prevalence between different methods of measurement of MDR-TB and study designs. MDR-TB prevalence in previously treated cases was found to be 35% (95% CI 29%-41%, I(2) = 98.7%). Results vary with the method of measurement as well as the study design. CONCLUSION: MDR-TB prevalence in previously treated patients was found higher compared to the reported values in national surveys. There is a need for large scale cross-sectional study to verify the findings observed in this review. Wolters Kluwer - Medknow 2019-10-31 /pmc/articles/PMC6857375/ /pubmed/31742141 http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Charan, Jaykaran
Tank, Nitish
Reljic, Tea
Singh, Surjit
Bhardwaj, Pankaj
Kaur, Rimplejeet
Goyal, Jagdish P.
Kumar, Ambuj
Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title_full Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title_fullStr Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title_full_unstemmed Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title_short Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
title_sort prevalence of multidrug resistance tuberculosis in adult patients in india: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857375/
https://www.ncbi.nlm.nih.gov/pubmed/31742141
http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19
work_keys_str_mv AT charanjaykaran prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT tanknitish prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT reljictea prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT singhsurjit prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT bhardwajpankaj prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT kaurrimplejeet prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT goyaljagdishp prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis
AT kumarambuj prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis